CTHIn ForceLegislation
Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025
Part 4Indications relating to the endocrine system
Start here
Get a plain-English read of Part 4
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025.
Part 4—Indications relating to the endocrine system
- Indications relating to the endocrine system
- 1 Aid/assist thyroid hormone production Scientific Product presentation must not imply or refer to any thyroid related diseases.
- 2 Maintain/support adrenal gland health Traditional Product presentation must not imply or refer to any adrenal related diseases.
- 3 Maintain/support healthy adrenal gland function Traditional Product presentation must not imply or refer to any adrenal related diseases.
- 4 Maintain/support healthy pancreatic function Traditional Product presentation must not imply or refer to any pancreas related diseases.
- 5 Maintain/support healthy thyroid gland function Scientific or Traditional Product presentation must not imply or refer to any thyroid related diseases.
- 6 Maintain/support healthy thyroid hormones Scientific Product presentation must not imply or refer to any thyroid related diseases.
- 7 Maintain/support thyroid gland health Scientific or Traditional Product presentation must not imply or refer to any thyroid related diseases.
- 8 Thyroid tonic Traditional Product presentation must not imply or refer to any thyroid related diseases.